BioSpace News Archive

Drug Development

RegeneRx Biopharmaceuticals, Inc. Release: Patient Enrollment Completed in Phase 2 Trial with RGN-259 for the Treatment of Dry Eye

August 24, 2011
·
1 min read
Business

Bend Research and Xcelience Form Partnership to Speed Drug Product Intermediates to Early-Phase Clinical Trials

August 24, 2011
·
1 min read
BioCapital

Nuvilex’s SG Austria Affiliate Invited to Present at Key Cell and Gene Therapy Forum

August 24, 2011
·
1 min read
Biotech Bay

BioTime’s Subsidiary OncoCyte Corporation Expands Cancer Programs with $10 Million Equity Financing

August 24, 2011
·
7 min read
Drug Development

Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge Eating Disorder Treatment

August 24, 2011
·
1 min read
Lone Star Bio

Investigating Whether Hispanic Women Have a Biologically Distinct Type of Breast Cancer is the Focus of Yale University Study, Funded by Susan G. Komen for the Cure

August 24, 2011
·
1 min read
Biotech Bay

Prestigious Molecular Biology Journal Publishes Breakthrough Research Led by Dr. Andres Tellez: Milestone Achievement Reflects Robust Brain Trust at Biocodex

August 24, 2011
·
1 min read
BioMidwest

Zyga Technology, Inc. Announces Start of European Enrollment for the GLYDER(TM) Facet Resurfacing System Clinical Study

August 24, 2011
·
1 min read
Business

inVentiv Health Launches Consolidated Communications Company in Europe

August 24, 2011
·
4 min read
Pharm Country

Johnson & Johnson Release: Rottenstein Law Group Heeds Groundswell of Grievances Against Manufacturers of Defective, Dangerous Hip Replacement Devices

August 24, 2011
·
4 min read